AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $787,000 | +69.2% | 104,500 | +126.2% | 0.01% | +40.0% |
| Q2 2022 | $465,000 | -59.5% | 46,200 | -11.0% | 0.01% | -58.3% |
| Q3 2021 | $1,148,000 | +223.4% | 51,900 | +89.4% | 0.01% | +200.0% |
| Q2 2021 | $355,000 | +32.0% | 27,400 | +32.4% | 0.00% | +33.3% |
| Q1 2021 | $269,000 | -80.2% | 20,700 | -77.5% | 0.00% | -88.5% |
| Q3 2020 | $1,357,000 | -78.6% | 92,100 | -70.5% | 0.03% | -83.1% |
| Q4 2019 | $6,327,000 | – | 312,268 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
| AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
| NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
| ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
| Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
| HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |